Introduction Non-small cell lung cancer (NSCLC) harbouring EGFR exon 19 deletions or
L858R mutation usually respond to epidermal growth factor receptor–tyrosine kinase …

Methods In this multicentre, retrospective study, we enrolled NSCLC patients with non-
resistant uncommon EGFR mutations, which were defined as mutations other than L858R …

Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation
patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and …

Introduction Non-small cell lung cancer (NSCLC) harbouring EGFR exon 19 deletions or
L858R mutation usually respond to epidermal growth factor receptor–tyrosine kinase …

Introduction Non-small cell lung cancer (NSCLC) harbouring EGFR exon 19 deletions or
L858R mutation usually respond to epidermal growth factor receptor-tyrosine kinase …

Introduction Non-small cell lung cancer (NSCLC) harbouring EGFR exon 19 deletions or
L858R mutation usually respond to epidermal growth factor receptor–tyrosine kinase …